BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 16456881)

  • 1. Outer membrane vesicles from group B Neisseria meningitidis delta gna33 mutant: proteomic and immunological comparison with detergent-derived outer membrane vesicles.
    Ferrari G; Garaguso I; Adu-Bobie J; Doro F; Taddei AR; Biolchi A; Brunelli B; Giuliani MM; Pizza M; Norais N; Grandi G
    Proteomics; 2006 Mar; 6(6):1856-66. PubMed ID: 16456881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outer membrane vesicles of the VA-MENGOC-BC vaccine against serogroup B of Neisseria meningitidis: Analysis of protein components by two-dimensional gel electrophoresis and mass spectrometry.
    Uli L; Castellanos-Serra L; Betancourt L; Domínguez F; Barberá R; Sotolongo F; Guillén G; Pajón Feyt R
    Proteomics; 2006 Jun; 6(11):3389-99. PubMed ID: 16673438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein NMB0928 from Neisseria meningitidis serogroup B as a novel vaccine candidate.
    Delgado M; Yero D; Niebla O; González S; Climent Y; Pérez Y; Cobas K; Caballero E; García D; Pajón R
    Vaccine; 2007 Dec; 25(50):8420-31. PubMed ID: 17996338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis of Neisseria lactamica and N eisseria meningitidis outer membrane vesicle vaccine antigens.
    Vaughan TE; Skipp PJ; O'Connor CD; Hudson MJ; Vipond R; Elmore MJ; Gorringe AR
    Vaccine; 2006 Jun; 24(25):5277-93. PubMed ID: 16682101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98/254.
    Vipond C; Suker J; Jones C; Tang C; Feavers IM; Wheeler JX
    Proteomics; 2006 Jun; 6(11):3400-13. PubMed ID: 16645985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global proteomic profiling of native outer membrane vesicles derived from Escherichia coli.
    Lee EY; Bang JY; Park GW; Choi DS; Kang JS; Kim HJ; Park KS; Lee JO; Kim YK; Kwon KH; Kim KP; Gho YS
    Proteomics; 2007 Sep; 7(17):3143-53. PubMed ID: 17787032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process.
    van de Waterbeemd B; Streefland M; van der Ley P; Zomer B; van Dijken H; Martens D; Wijffels R; van der Pol L
    Vaccine; 2010 Jul; 28(30):4810-6. PubMed ID: 20483197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outer membrane vesicles (OMVs) and detoxified lipooligosaccharide (dLOS) obtained from Brazilian prevalent N. meningitidis serogroup B strains protect mice against homologous and heterologous meningococcal infection and septic shock.
    Jessouroun E; da Silveira IF; Larangeira AP; Pereira S; Fernandes SA; Rabinovitch L; Frasch CE; Castro-Faria-Neto HC; Bozza PT
    Vaccine; 2004 Jun; 22(20):2617-25. PubMed ID: 15193387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with meningococcal outer-membrane protein vesicles containing lipooligosaccharide protects mice against lethal experimental group B Neisseria meningitidis infection and septic shock.
    Quakyi EK; Frasch CE; Buller N; Tsai CM
    J Infect Dis; 1999 Sep; 180(3):747-54. PubMed ID: 10438363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of meningococcal serogroup B outer membrane vesicle vaccines from strain 44/76 after growth in different media.
    Tsolakos N; Lie K; Bolstad K; Maslen S; Kristiansen PA; Høiby EA; Wallington A; Vipond C; Skehel M; Tang CM; Feavers IM; Wedege E; Wheeler JX
    Vaccine; 2010 Apr; 28(18):3211-8. PubMed ID: 20188677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outer membrane protein (OMP) based vaccine for Neisseria meningitidis serogroup B.
    Pillai S; Howell A; Alexander K; Bentley BE; Jiang HQ; Ambrose K; Zhu D; Zlotnick G
    Vaccine; 2005 Mar; 23(17-18):2206-9. PubMed ID: 15755596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outer membrane proteome of Actinobacillus pleuropneumoniae: LC-MS/MS analyses validate in silico predictions.
    Chung JW; Ng-Thow-Hing C; Budman LI; Gibbs BF; Nash JH; Jacques M; Coulton JW
    Proteomics; 2007 Jun; 7(11):1854-65. PubMed ID: 17476711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic analysis of outer membranes and vesicles from wild-type serogroup B Neisseria meningitidis and a lipopolysaccharide-deficient mutant.
    Williams JN; Skipp PJ; Humphries HE; Christodoulides M; O'Connor CD; Heckels JE
    Infect Immun; 2007 Mar; 75(3):1364-72. PubMed ID: 17158897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of vaccine potential of the Neisseria-specific protein NMB0938.
    Sardiñas G; Climent Y; Rodríguez Y; González S; García D; Cobas K; Caballero E; Pérez Y; Brookes C; Taylor S; Gorringe A; Delgado M; Pajón R; Yero D
    Vaccine; 2009 Nov; 27(49):6910-7. PubMed ID: 19751688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic characterization and functional analysis of outer membrane vesicles of Francisella novicida suggests possible role in virulence and use as a vaccine.
    Pierson T; Matrakas D; Taylor YU; Manyam G; Morozov VN; Zhou W; van Hoek ML
    J Proteome Res; 2011 Mar; 10(3):954-67. PubMed ID: 21138299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis.
    Holst J; Martin D; Arnold R; Huergo CC; Oster P; O'Hallahan J; Rosenqvist E
    Vaccine; 2009 Jun; 27 Suppl 2():B3-12. PubMed ID: 19481313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outer membrane vesicles as acellular vaccine against pertussis.
    Roberts R; Moreno G; Bottero D; Gaillard ME; Fingermann M; Graieb A; Rumbo M; Hozbor D
    Vaccine; 2008 Aug; 26(36):4639-46. PubMed ID: 18640169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the immune response to Neisseria meningitidis using a proteomics approach.
    Williams JN; Christodoulides M; Heckels JE
    Methods Mol Biol; 2012; 799():343-60. PubMed ID: 21993655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative proteomics reveals distinct differences in the protein content of outer membrane vesicle vaccines.
    van de Waterbeemd B; Mommen GP; Pennings JL; Eppink MH; Wijffels RH; van der Pol LA; de Jong AP
    J Proteome Res; 2013 Apr; 12(4):1898-908. PubMed ID: 23410224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterizations of serogroup B Neisseria meningitidis strains circulating in Beijing.
    Zhang TG; Chen C; He JG; Wu J; Chen LJ; Pang XH; Yang J; Shao ZJ; Huang YC
    Chin Med J (Engl); 2009 Mar; 122(5):584-7. PubMed ID: 19323912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.